Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead

R Boia, N Ruzafa, ID Aires, X Pereiro… - International journal of …, 2020 - mdpi.com
The retinal ganglion cells (RGCs) are the output cells of the retina into the brain. In
mammals, these cells are not able to regenerate their axons after optic nerve injury, leaving …

Transneuronal degeneration in the brain during glaucoma

M You, R Rong, Z Zeng, X Xia, D Ji - Frontiers in aging neuroscience, 2021 - frontiersin.org
The death of retinal ganglion cells (RGCs) is a key factor in the pathophysiology of all types
of glaucoma, but the mechanism of pathogenesis of glaucoma remains unclear. RGCs are a …

The concept of gene therapy for glaucoma: the dream that has not come true yet

R Sulak, X Liu, A Smedowski - Neural regeneration research, 2024 - journals.lww.com
Gene therapies, despite of being a relatively new therapeutic approach, have a potential to
become an important alternative to current treatment strategies in glaucoma. Since …

Magnesium acetyltaurate prevents retinal damage and visual impairment in rats through suppression of NMDA-induced upregulation of NF-κB, p53 and AP-1 (c-Jun/c …

L Lambuk, I Iezhitsa, R Agarwal… - Neural Regeneration …, 2021 - journals.lww.com
Magnesium acetyltaurate (MgAT) has been shown to have a protective effect against N-
methyl-D-aspartate (NMDA)-induced retinal cell apoptosis. The current study investigated …

Inhibition of Nogo-A rescues synaptic plasticity and associativity in APP/PS1 animal model of Alzheimer's disease

MV Pavon, S Navakkode, LW Wong… - Seminars in cell & …, 2023 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
memory loss and cognitive decline. Synaptic impairment is one of the first events to occur in …

[HTML][HTML] Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies

EF Biyong, C Tremblay, M Leclerc, V Caron… - Neurobiology of …, 2021 - Elsevier
Abstract Background Vitamin A (VitA), via its active metabolite retinoic acid (RA), is critical for
the maintenance of memory function with advancing age. Although its role in Alzheimer's …

Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury

J Baya Mdzomba, S Joly, L Rodriguez, A Dirani… - Cell death & …, 2020 - nature.com
Abstract N-Methyl-D-aspartate (NMDA)-induced neuronal cell death is involved in a large
spectrum of diseases affecting the brain and the retina such as Alzheimer's disease and …

B cell-dependent EAE induces visual deficits in the mouse with similarities to human autoimmune demyelinating diseases

S Joly, JB Mdzomba, L Rodriguez, F Morin… - Journal of …, 2022 - Springer
Background In the field of autoimmune demyelinating diseases, visual impairments have
extensively been studied using the experimental autoimmune encephalomyelitis (EAE) …

Recovery after spinal cord injury is enhanced by anti-Nogo-A antibody therapy—from animal models to clinical trials

AM Sartori, AS Hofer, ME Schwab - Current Opinion in Physiology, 2020 - Elsevier
The ability of the central nervous system to regenerate over long distances after a lesion is
restricted by the presence of physical and biochemical barriers, neuronal growth programs …

[HTML][HTML] A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress

LH Wu, YW Cheng, FL Lin, KC Hsu, MH Wang… - Biomedicine & …, 2024 - Elsevier
Glaucoma is considered a neurodegenerative disease characterized by progressive visual
field defects that may lead to blindness. Although controlling intraocular pressure (IOP) is the …